+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Clear cell sarcoma - Epidemiology Forecast - 2032 - Product Thumbnail Image

Clear cell sarcoma - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Epithelioid Sarcoma - Epidemiology Forecast - 2032 - Product Thumbnail Image

Epithelioid Sarcoma - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
Neuroendocrine Tumors - Epidemiology Forecast to 2032 - Product Thumbnail Image

Neuroendocrine Tumors - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
From
From
From
Pediatric Neuroblastoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Pediatric Neuroblastoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
T-cell malignancies - Epidemiology Forecast - 2032 - Product Thumbnail Image

T-cell malignancies - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
KRAS Mutant Cancer - Epidemiology Forecast - 2032 - Product Thumbnail Image

KRAS Mutant Cancer - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Malignant Pleural Mesothelioma - Epidemiology Forecast - 2032 - Product Thumbnail Image

Malignant Pleural Mesothelioma - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Metastatic Cutaneous Melanoma - Epidemiology Forecast - 2032 - Product Thumbnail Image

Metastatic Cutaneous Melanoma - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Multiple Osteochondromas (MO) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Multiple Osteochondromas (MO) - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Gastroesophgeal adenocarcinoma -Epidemiology Forecast -2032 - Product Thumbnail Image

Gastroesophgeal adenocarcinoma -Epidemiology Forecast -2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Primary Myelofibrosis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Primary Myelofibrosis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
HER+ Gastric Cancer - Epidemiology Forecast - 2032 - Product Thumbnail Image

HER+ Gastric Cancer - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more